(Q57693948)

English

Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials

scientific article published on 29 April 2011

Statements

Baseline circulating tumor cell counts significantly enhance a prognostic score for patients participating in phase I oncology trials (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit